Race Oncology Limited (RAC.AX)

AUD 0.98

(-3.92%)

Total Assets Summary of Race Oncology Limited

  • Race Oncology Limited's latest annual total assets in 2024 was 20.22 Million AUD , down -24.06% from previous year.
  • Race Oncology Limited's latest quarterly total assets in 2024 FY was 20.22 Million AUD , down -24.06% from previous quarter.
  • Race Oncology Limited reported annual total assets of 26.63 Million AUD in 2023, down -29.01% from previous year.
  • Race Oncology Limited reported annual total assets of 37.52 Million AUD in 2022, up 163.41% from previous year.
  • Race Oncology Limited reported quarterly total assets of 21.07 Million AUD for 2024 Q2, down 0.0% from previous quarter.
  • Race Oncology Limited reported quarterly total assets of 20.22 Million AUD for 2024 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of Race Oncology Limited (2024 - 2013)

Historical Annual Total Assets of Race Oncology Limited (2024 - 2013)

Year Total Assets Total Assets Growth
2024 20.22 Million AUD -24.06%
2023 26.63 Million AUD -29.01%
2022 37.52 Million AUD 163.41%
2021 14.24 Million AUD 140.08%
2020 5.93 Million AUD 13.19%
2019 5.24 Million AUD -36.39%
2018 8.24 Million AUD 37.32%
2017 6 Million AUD 34.26%
2016 4.46 Million AUD 3490.93%
2015 124.46 Thousand AUD 101.4%
2014 61.8 Thousand AUD -41.27%
2013 105.22 Thousand AUD 0.0%

Peer Total Assets Comparison of Race Oncology Limited

Name Total Assets Total Assets Difference
AdAlta Limited 5.57 Million AUD -262.975%
Biome Australia Limited 8.27 Million AUD -144.401%
Radiopharm Theranostics Limited 72.03 Million AUD 71.919%
Biotron Limited 493.47 Thousand AUD -3999.201%
Acrux Limited 8.96 Million AUD -125.69%
Alterity Therapeutics Limited 19.22 Million AUD -5.227%
Botanix Pharmaceuticals Limited 112.46 Million AUD 82.013%
BTC Health Limited 5.14 Million AUD -292.879%
Chimeric Therapeutics Limited 15.27 Million AUD -32.445%
CSL Limited 56.93 Billion AUD 99.964%
Clarity Pharmaceuticals Ltd 154.62 Million AUD 86.918%
Clinuvel Pharmaceuticals Limited 231.12 Million AUD 91.248%
Immutep Limited 147.44 Million AUD 86.281%
Memphasys Limited 12.43 Million AUD -62.738%
Neuren Pharmaceuticals Limited 247.97 Million AUD 91.842%
Noxopharm Limited 6.78 Million AUD -198.191%
Prescient Therapeutics Limited 20.39 Million AUD 0.806%
Starpharma Holdings Limited 36.81 Million AUD 45.052%
Tissue Repair Ltd 19.38 Million AUD -4.327%
EZZ Life Science Holdings Limited 25.55 Million AUD 20.834%
Anatara Lifesciences Ltd 1.67 Million AUD -1110.261%
Bio-Gene Technology Limited 3.15 Million AUD -540.228%
Zelira Therapeutics Limited 5.18 Million AUD -290.256%
Patrys Limited 4.16 Million AUD -386.079%
Orthocell Limited 26.61 Million AUD 23.996%
Imugene Limited 151.39 Million AUD 86.639%
PYC Therapeutics Limited 91.23 Million AUD 77.829%
Proteomics International Laboratories Limited 10.87 Million AUD -86.008%
Cynata Therapeutics Limited 8.38 Million AUD -141.153%
Arovella Therapeutics Limited 13.28 Million AUD -52.27%
Nanollose Limited 241.95 Thousand AUD -8260.607%
Invex Therapeutics Ltd 6.12 Million AUD -230.529%
NeuroScientific Biopharmaceuticals Limited 5.43 Million AUD -272.131%
Amplia Therapeutics Limited 14.84 Million AUD -36.264%
Island Pharmaceuticals Limited 2.56 Million AUD -688.801%
Nyrada Inc. 5.9 Million AUD -242.436%
Telix Pharmaceuticals Limited 398.3 Million AUD 94.921%
Dimerix Limited 32.07 Million AUD 36.94%
PharmAust Limited 11.12 Million AUD -81.832%
Hexima Limited 2.26 Million AUD -791.518%
AnteoTech Limited 9.38 Million AUD -115.629%
Paradigm Biopharmaceuticals Limited 27.39 Million AUD 26.147%
Recce Pharmaceuticals Ltd 6.36 Million AUD -217.579%
Avecho Biotechnology Limited 7.31 Million AUD -176.373%
Actinogen Medical Limited 21.31 Million AUD 5.083%
Immuron Limited 15.54 Million AUD -30.088%
Argenica Therapeutics Limited 16.37 Million AUD -23.514%